Free Trial
NYSE:NEUE

NeueHealth Q3 2025 Earnings Report

NeueHealth logo
$6.75 0.00 (0.00%)
As of 10/8/2025

NeueHealth EPS Results

Actual EPS
N/A
Consensus EPS
-$2.73
Beat/Miss
N/A
One Year Ago EPS
N/A

NeueHealth Revenue Results

Actual Revenue
N/A
Expected Revenue
$256.80 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeueHealth Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, November 6, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

NeueHealth Earnings Headlines

NeueHealth Announces Closing of Take-Private Transaction
How to get compound interest working on your portfolio
I’ve narrowed the entire S&P 500 down to the dividend stocks I’d actually buy myself — including two I’ve already invested $50,000 into — and you can see them all in my free Five Dividend Investing Cheat Sheets.tc pixel
NeueHealth Reports Second Quarter 2025 Results
See More NeueHealth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeueHealth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeueHealth and other key companies, straight to your email.

About NeueHealth

NeueHealth (NYSE:NEUE) is a technology‐enabled healthcare services company that partners with health plans and providers to deliver value‐based care solutions. Its core offerings include a proprietary population health management platform, risk adjustment services, patient engagement tools and care coordination support. Through data analytics and integrated care teams, NeueHealth aims to optimize outcomes for members enrolled in Medicare Advantage and other government‐sponsored plans.

Founded in 2020 and headquartered in New York, NeueHealth leverages a mix of digital outreach and live care management to identify care gaps, support chronic condition management and drive quality performance. The company’s platform integrates claims data, clinical records and member-reported information to stratify risk and guide timely interventions. By aligning incentives with its payer and provider partners, NeueHealth seeks to reduce total cost of care while improving patient satisfaction and health outcomes.

Following its merger with a special purpose acquisition company and subsequent listing on the New York Stock Exchange under the ticker NEUE, NeueHealth has expanded its footprint across the United States. The company’s leadership team comprises veteran executives from both the healthcare and technology sectors, focusing on scaling operations, enhancing its software capabilities and forging new partnerships with health systems and insurers.

View NeueHealth Profile

More Earnings Resources from MarketBeat